This page may contain stale information. Last updated: 2026-04-29
Overview
Pancreatic cancer refers to malignant tumors that form in the pancreas, a glandular organ located behind the stomach. Pancreatic ductal adenocarcinoma (PDAC) is the most common type, accounting for approximately 90% of pancreatic cancer cases.
Key Statistics
- 5-Year Survival Rate: ~12% (among the lowest of all cancers)
- Detection Challenge: Often diagnosed at advanced stages
- Symptoms: Typically no early symptoms; weight loss, jaundice, and abdominal pain appear late
- Risk Factors: Smoking, obesity, diabetes, family history, chronic pancreatitis
Clinical Significance
Pancreatic cancer’s low survival rate is largely attributable to:
- Lack of effective screening methods
- Rapid progression
- Late-stage diagnosis when metastases have occurred
- Limited treatment options for advanced disease
AI Detection Breakthrough (2026)
REDMOD System
Mayo Clinic’s REDMOD AI achieved:
- 73% detection accuracy vs 39% for experienced radiologists
- 475 days average early detection before clinical diagnosis
- Analysis performed on routine contrast-enhanced CT scans
This represents a paradigm shift in pancreatic cancer detection, potentially enabling:
- Earlier surgical intervention
- Improved patient outcomes
- Better use of healthcare resources
Related Concepts
- early-cancer-detection: General early detection strategies
- medical-ai: AI applications in healthcare
- healthcare-ai: Broader healthcare AI context
Related Entities
- mayo-clinic: Research institution behind REDMOD
- redmod: The specific AI system for pancreatic cancer detection